Cue Biopharma, Inc. Contracts & Agreements

91 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Second Amendment to Loan and Security Agreement, dated October 2, 2024, by and between Silicon Valley Bank, a division of First-Citizens Bank & Trust Company, and Cue Biopharma,...
Loan Agreements
Cue Biopharma, Inc.
2024
Underwriting Agreement, dated September 26, 2024, by and between Cue Biopharma, Inc. and Oppenheimer & Co. Inc., as representative of the underwriters named therein
Underwriting Agreements
Cue Biopharma, Inc.
2024
Form of Pre-Funded Warrant
Warrant Agreements
Cue Biopharma, Inc.
2024
Form of Common Stock Warrant
Warrant Agreements
Cue Biopharma, Inc.
2024
Form of stock option award under 2016 Omnibus Incentive Plan
Bonus & Incentive Agreements
Cue Biopharma, Inc.
2024
Form of stock option award under 2016 Non-Employee Equity Incentive Plan
Bonus & Incentive Agreements
Cue Biopharma, Inc.
2024
Description of Common Stock of the Registrant Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Stock Agreements
Cue Biopharma, Inc.
2024
Director Compensation Policy effective December 7, 2023
Compensation Agreements
Cue Biopharma, Inc.
2024
Second Amendment to the Amended and Restated License Agreement with Albert Einstein College of Medicine dated January 13, 2024
License Agreements
Cue Biopharma, Inc.
2024
Amendment No. 1 to Consulting Agreement between Cue Biopharma, Inc. and Peter A. Kiener, dated September 1, 2023
Consulting Agreements
Cue Biopharma, Inc.
2023
Amendment No. 2 to Cue Biopharma, Inc. 2016 Omnibus Incentive Plan
Bonus & Incentive Agreements
Cue Biopharma, Inc.
2023
Amendment No. 1 to Cue Biopharma, Inc. 2016 Non-Employee Equity Incentive Plan
Bonus & Incentive Agreements
Cue Biopharma, Inc.
2023
Consulting Agreement effective June 7, 2023 entered into between Cue Biopharma, Inc. and Peter A Kiener, D.Phil
Consulting Agreements
Cue Biopharma, Inc.
2023
Registration Rights Agreement, dated November 14, 2022, by and among the Company and the other parties thereto
Registration Rights Agreements
Cue Biopharma, Inc.
2022
Form of Securities Purchase Agreement, dated November 14, 2022, by and among the Company and the other parties thereto
Purchase Agreements
Cue Biopharma, Inc.
2022
Form of Warrant to Purchase Common Stock or Pre-Funded Warrant to be issued pursuant to the Securities Purchase Agreement
Warrant Agreements
Cue Biopharma, Inc.
2022
Form of Pre-Funded Warrant to Purchase Common Stock to be issued pursuant to the Securities Purchase Agreement
Warrant Agreements
Cue Biopharma, Inc.
Biotechnology
NY
2022
Termination of License Agreement, dated September 9, 2022, between Cue Biopharma, Inc. and MIL 21E, LLC
Termination Agreements
Cue Biopharma, Inc.
2022
Rider to License Agreement, dated as of July 7, 2022, between Cue Biopharma, Inc. and MIL 40G, LLC
License Agreements
Cue Biopharma, Inc.
2022
First Amendment to the License Agreement, dated May 3, 2022, between Cue Biopharma, Inc. and MIL 40G, LLC
License Agreements
Cue Biopharma, Inc.
Biotechnology
2022
Director Compensation Policy dated January 1, 2021
Compensation Agreements
Cue Biopharma, Inc.
2022
License Agreement, March 28, 2022
License Agreements
Cue Biopharma, Inc.
2022
Loan and Security Agreement, dated February 15, 2022, by and between Cue Biopharma, Inc. and Silicon Valley Bank
Loan Agreements
Cue Biopharma, Inc.
2022
Consulting Agreement, dated January 1, 2017, between the Registrant and Ken Pienta, as amended by Amendment No. 1 to Consulting Agreement dated December 15, 2021
Consulting Agreements
Cue Biopharma, Inc.
Biotechnology
MA
2022
Open Market Sale AgreementSM, dated October 1, 2021, by and between Cue Biopharma, Inc. and Jefferies LLC
Cue Biopharma, Inc.
2021
Third Amendment to License Agreement, dated October 22, 2021, by and between Cue Biopharma, Inc. and MIL 21E, LLC
License Agreements
Cue Biopharma, Inc.
2021
Open Market Sale AgreementSM, dated October 1, 2021, by and between Cue Biopharma, Inc. and Jefferies LLC
Cue Biopharma, Inc.
Biotechnology
NY
2021
Second Amendment to Collaboration, License and Option Agreement, dated August 5, 2019, between the Registrant and LG CHEM LTD
Collaboration Agreements
Cue Biopharma, Inc.
2021
First Amendment to the Exclusive Patent License and Research Collaboration Agreement with Merck Sharp & Dohme Corp. dated November 9, 2020
Collaboration Agreements
Cue Biopharma, Inc.
2021
Third Amended and Restated Executive Employment Agreement dated March 4, 2021 between the Company and Daniel Passeri
Employment Agreements
Cue Biopharma, Inc.
2021
Eighth Amendment to Collaboration, License and Option Agreement, dated December 7, 2020, between the Registrant and LG CHEM LTD
Collaboration Agreements
Cue Biopharma, Inc.
Biotechnology
2021
Seventh Amendment to Collaboration, License and Option Agreement, dated May 14, 2020, between the Registrant and LG CHEM LTD
Collaboration Agreements
Cue Biopharma, Inc.
2021
Sixth Amendment to Collaboration, License and Option Agreement, dated February 14, 2020, between the Registrant and LG CHEM LTD
Collaboration Agreements
Cue Biopharma, Inc.
Biotechnology
2021
Fifth Amendment to Collaboration, License and Option Agreement, dated January 10, 2020, between the Registrant and LG CHEM LTD
Collaboration Agreements
Cue Biopharma, Inc.
Biotechnology
2021
Fourth Amendment to Collaboration, License and Option Agreement, dated December 18, 2019, between the Registrant and LG CHEM LTD
Collaboration Agreements
Cue Biopharma, Inc.
2021
Third Amendment to Collaboration, License and Option Agreement, dated October 29, 2019, between the Registrant and LG CHEM LTD
Collaboration Agreements
Cue Biopharma, Inc.
2021
First Amendment to Collaboration, License and Option Agreement, dated March 15, 2019, between the Registrant and LG CHEM LTD
Collaboration Agreements
Cue Biopharma, Inc.
2021
First Amendment to the Amended and Restated License Agreement with Albert Einstein College of Medicine dated October 30, 2018
License Agreements
Cue Biopharma, Inc.
Biotechnology
2021
Third Amendment to Vivarium Agreement, dated July 20, 2020, between the Registrant and MIL 21E, LLC
Cue Biopharma, Inc.
Biotechnology
2020
Executive Employment Agreement dated August 21, 2020 between the Company and Kerri-Ann Millar
Employment Agreements
Cue Biopharma, Inc.
2020
Second Amendment to License Agreement between the Registrant and MIL 21E, LLC
License Agreements
Cue Biopharma, Inc.
2020
At-the-Market Equity Offering Sales Agreement by and between Cue Biopharma, Inc. and Stifel, Nicolaus & Company, Incorporated, dated June 22, 2020
Sales Agreements
Cue Biopharma, Inc.
Biotechnology
NY
2020
At-the-Market Equity Offering Sales Agreement by and between Cue Biopharma, Inc. and Stifel, Nicolaus & Company, Incorporated, dated March 27, 2020
Sales Agreements
Cue Biopharma, Inc.
Biotechnology
NY
2020
Amendment No. 1 to Cue Biopharma, Inc. 2016 Omnibus Incentive Plan
Bonus & Incentive Agreements
Cue Biopharma, Inc.
Biotechnology
DE
2020
Description of Common Stock of the Registrant Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Stock Agreements
Cue Biopharma, Inc.
2020
Second Amended and Restated Executive Employment Agreement dated February 10, 2020 between the Company and Daniel Passeri
Employment Agreements
Cue Biopharma, Inc.
2020
At-the-Market Equity Offering Sales Agreement by and between Cue Biopharma, Inc. and Stifel, Nicolaus & Company, Incorporated, dated November 25, 2019
Sales Agreements
Cue Biopharma, Inc.
Biotechnology
NY
2019
Amended and Restated Executive Employment Agreement dated October 3, 2019 between the Company and Daniel Passeri
Employment Agreements
Cue Biopharma, Inc.
2019
Amended and Restated Executive Employment Agreement dated October 3, 2019 between the Company and Anish Suri
Employment Agreements
Cue Biopharma, Inc.
Biotechnology
DE
2019
At-the-Market Equity Offering Sales Agreement by and between Cue Biopharma, Inc. and Stifel, Nicolaus & Company, Incorporated, dated June 5, 2019
Sales Agreements
Cue Biopharma, Inc.
2019
Director Compensation Policy dated October 30, 2018
Compensation Agreements
Cue Biopharma, Inc.
2019
Collaboration, License and Option Agreement, by and between the Company and LG Chem, Ltd., dated as of November 6, 2018
Collaboration Agreements
Cue Biopharma, Inc.
2018
Collaboration, License and Option Agreement, by and between the Company and LG Chem, Ltd., dated as of November 6, 2018
Collaboration Agreements
Cue Biopharma, Inc.
2018
Executive Employment Agreement between the Registrant and Anish Suri dated as of April, 2018
Employment Agreements
Cue Biopharma, Inc.
Biotechnology
MA
2018
Executive Employment Agreement between the Registrant and Bethany Mancilla dated as of June 22, 2018
Employment Agreements
Cue Biopharma, Inc.
Biotechnology
MA
2018
First Amendment to License Agreement between the Registrant and MIL 21E, LLC dated June 18, 2018
License Agreements
Cue Biopharma, Inc.
Biotechnology
2018
License Agreement between the Registrant and MIL 21E, LLC dated January 19, 2018
License Agreements
Cue Biopharma, Inc.
2018
Warrant issued to Paulson Investment Company LLC (U2017-3) dated December 27, 2017
Warrant Agreements
Cue Biopharma, Inc.
2018
Warrant issued to Feltl and Company, Inc. (U2017-2) dated December 27, 2017
Warrant Agreements
Cue Biopharma, Inc.
2018
Warrant issued to MDB Capital Group, LLC (U2017-1) dated December 27, 2017
Warrant Agreements
Cue Biopharma, Inc.
Biotechnology
2018
Exclusive Patent License and Research Collaboration Agreement between the Registrant and Merck Sharp & Dohme Corp. dated November 14, 2017
Collaboration Agreements
Cue Biopharma, Inc.
2017
Amended and Restated License Agreement by and between the Registrant and Albert Einstein College of Medicine dated July 31, 2017
License Agreements
Cue Biopharma, Inc.
2017
Exclusive Patent License and Research Collaboration Agreement between the Registrant and Merck Sharp & Dohme Corp. dated November 14, 2017
Collaboration Agreements
Cue Biopharma, Inc.
2017
Amended and Restated License Agreement by and between the Registrant and Albert Einstein College of Medicine dated July 31, 2017
License Agreements
Cue Biopharma, Inc.
Biotechnology
NY
2017
Escrow Agreement for the offering by and between the Registrant, MDB Capital Group, LLC and Continental Stock Transfer & Trust Company dated November 24, 2017
Escrow Agreements
Cue Biopharma, Inc.
Biotechnology
NY
2017
Form of Underwriting Agreement
Underwriting Agreements
Cue Biopharma, Inc.
2017
Specimen Certificate representing shares of common stock of the Registrant
Stock Agreements
Cue Biopharma, Inc.
2017
Form of Underwriters Warrant
Warrant Agreements
Cue Biopharma, Inc.
Biotechnology
2017
Form of Lock-Up Agreement
Cue Biopharma, Inc.
2017
Form of Subscription Agreement for the offering
Subscription Agreements
Cue Biopharma, Inc.
2017
Exclusive Patent License and Research Collaboration Agreement between the Registrant and Merck Sharp & Dohme Corp. dated November 14, 2017
Collaboration Agreements
Cue Biopharma, Inc.
Biotechnology
NY
2017
Executive Employment Agreement between the Registrant and Colin G. Sandercock dated as of November 15, 2017
Employment Agreements
Cue Biopharma, Inc.
2017
Form of Irrevocable Waiver and Amendment to Securities Purchase Agreements between the Registrant and investors for offerings completed June 15, 2015 and December 22, 2016
Purchase Agreements
Cue Biopharma, Inc.
Biotechnology
DE
2017
Executive Employment Agreement between the Registrant and Rodolfo J. Chaparro dated effective June 15, 2015
Employment Agreements
Cue Biopharma, Inc.
2017
Warrant to Purchase Common Stock issued to the placement agent in the Registrants 2015 private placement offering
Warrant Agreements
Cue Biopharma, Inc.
2017
Engagement Agreement dated April 13, 2015 between the Registrant and MDB Capital Group, LLC
Cue Biopharma, Inc.
2017
Form of Securities Purchase Agreement between the Registrant and investors for an offering completed on June 15, 2015
Purchase Agreements
Cue Biopharma, Inc.
2017
Form of Registration Rights Agreement between the Registrant and investors for an offering completed on June 15, 2015
Registration Rights Agreements
Cue Biopharma, Inc.
Biotechnology
NY
2017
Form of Securities Purchase Agreement between the Registrant and investors for an offering completed on December 22, 2016
Purchase Agreements
Cue Biopharma, Inc.
Biotechnology
MA
2017
Form of Joinder and Amendment to Registration Rights Agreement between the Registrant and investors for an offering completed on December 22, 2016
Registration Rights Agreements
Cue Biopharma, Inc.
2017
Employment Agreement between the Registrant and Daniel R. Passeri dated August 29, 2016
Employment Agreements
Cue Biopharma, Inc.
Biotechnology
MA
2017
Executive Employment Agreement between the Registrant and Ronald D. Seidel dated effective June 15, 2015
Employment Agreements
Cue Biopharma, Inc.
2017
Second Amendment to Real Estate License Agreement by and between the Registrant and Mass Innovation Labs, LLC dated June 28, 2017
License Agreements
Cue Biopharma, Inc.
Biotechnology
2017
Amendment to Real Estate License Agreement by and between the Registrant and Mass Innovation Labs, LLC dated November 14, 2016
License Agreements
Cue Biopharma, Inc.
Biotechnology
2017
Real Estate License Agreement by and between the Registrant and Mass Innovation Labs, LLC dated July 29, 2015
License Agreements
Cue Biopharma, Inc.
2017
Form of stock option award under 2016 Non-Employee Equity Incentive Plan
Bonus & Incentive Agreements
Cue Biopharma, Inc.
Biotechnology
MA
2017
Cue Biopharma, Inc. 2016 Non-Employee Equity Incentive Plan
Bonus & Incentive Agreements
Cue Biopharma, Inc.
Biotechnology
DE
2017
Form of stock option award under 2016 Omnibus Incentive Plan
Bonus & Incentive Agreements
Cue Biopharma, Inc.
Biotechnology
MA
2017
Cue Biopharma, Inc. 2016 Omnibus Incentive Plan, as amended and restated
Bonus & Incentive Agreements
Cue Biopharma, Inc.
2017
Amended and Restated License Agreement by and between the Registrant and Albert Einstein College of Medicine dated July 31, 2017
License Agreements
Cue Biopharma, Inc.
2017
Form of Indemnification Agreement
Indemnification Agreements
Cue Biopharma, Inc.
Biotechnology
DE
2017